Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076505 · ClinicalTrials.gov registry record
Cell Studies of Parkinson's Disease
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 150
- Enrollment target
NCT00076505: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT00076505 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00076505 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study will examine and compare blood samples from healthy volunteers and patients with Parkinson's disease to identify abnormalities associated with Parkinson's disease. Disease symptoms include slowness of movement, hand or leg shaking, and stiffness. Some patients have difficulty with balance. Information from this study may provide information on how Parkinson's disease affects the brain and body, and may help lead to a test for earlier diagnosis. Healthy volunteers and patients with Parkinson's disease who are 18 years of age or older may enroll in this study. Participants will undergo the following procedures: * Physical examination, including evaluation of strength, feeling, coordination, and balance * Blood drawing: 150 milliliters (about 10 tablespoons) of blood will be drawn * Personal and family medical history * Consent to access medical records for research purposes Blood samples will be examined for: * Genetic analysis * Study of specific proteins and lipids * Study of mitochondria (parts of cells that make energy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2004-01-14 |
| Est. Completion | 2006-11-30 |
What the finished NCT00076505 record still lists
NCT00076505 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00076505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00076505 about?
NCT00076505 is a clinical study titled "Cell Studies of Parkinson's Disease". This study will examine and compare blood samples from healthy volunteers and patients with Parkinson's disease to identify abnormalities associated with Parkinson's disease. Disease symptoms include slowness of movement, hand or leg shaking, and stiffness. Some patients have difficulty with balance...
What is the current status of trial NCT00076505?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2004-01-14. Estimated completion is 2006-11-30.
Who is sponsoring clinical trial NCT00076505?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI